Matt Posard has joined the board of directors of Halozyme Therapeutics, a biopharmaceutical company. Posard is currently Illumina's senior vice president and general manager of translational and consumer genomics. He has worked for the San Diego-based array vendor since 2006, serving first as its vice president of global marketing and then later as vice president of global sales. Prior to joining Illumina, Posard held various marketing positions at Gen-Probe and Biosite.
People in the News: Matt Posard
Apr 03, 2013